160 results on '"Burmeister, Bryan H."'
Search Results
2. Utility of 30-day mortality as a quality metric for palliative radiation treatment: A population-based analysis from Queensland, Australia.
3. Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
4. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial
5. Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy
6. Esophagus Carcinoma Surveillance Counterpoint: Australia
7. Stage III Melanoma in the Axilla: Patterns of Regional Recurrence After Surgery With and Without Adjuvant Radiation Therapy
8. The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)
9. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
10. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
11. T1-2 anal carcinoma requires elective inguinal radiation treatment – The results of Trans Tasman Radiation Oncology Group study TROG 99.02
12. Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction
13. Melanoma brain metastases: the impact of nodal disease
14. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer
15. Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery in esophageal or gastro-esophageal carcinoma.
16. Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction
17. A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer
18. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial”
19. Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin
20. Promising Results of a Cooperative Group Phase II Trial of Preoperative Chemoradiation for Locally Advanced Rectal Cancer (TROG 9801)
21. Esophagus Carcinoma Surveillance Counterpoint: Australia
22. Synchronous postoperative adjuvant chemoradiation therapy for locally advanced carcinoma of the rectum
23. Economic analysis of FDG-PET–guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma9
24. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06
25. A Randomized Phase II Trial of Two Regimens of Moderate Dose Chemoradiation Therapy for Patients with Non-small Cell Lung Cancer Not Suitable for Curative Therapy: Trans Tasman Radiation Oncology Study TROG 03.07
26. Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy
27. Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
28. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
29. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05)
30. Two cases of esophageal carcinoma following corrosive esophagitis successfully treated with chemoradiation therapy
31. Thirty-four Patients With Carcinoma of the Cervical Esophagus Treated With Chemoradiation Therapy
32. Phase 3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1-3 melanoma brain metastases (MBMs).
33. Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus
34. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group
35. A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-Tasman Radiation Oncology Group, TROG 96.05)
36. Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus
37. Neck dissection rate in node positive human papillomavirus associated oropharyngeal carcinoma following chemoradiotherapy.
38. Radiation therapy
39. A phase 2 study of intralesional PV-10 followed by radiotherapy for localized in transit or recurrent metastatic melanoma.
40. Role of radiotherapy in the pre-operative management of carcinoma of the esophagus
41. Melanoma brain metastases: the impact of nodal disease
42. Targeted therapy and chemoradiotherapy in oesophageal cancer
43. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma
44. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
45. A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series
46. Role of Functional Imaging in Head and Neck Squamous Cell Carcinoma: Fluorodeoxyglucose Positron Emission Tomography and Beyond
47. A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer
48. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05)
49. Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors' reply
50. Combined modality therapy for carcinoma of the oesophagus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.